Alpha-Defensin vs Teriparatide

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Alpha-Defensin

Alpha-defensins are small cationic peptides that are key components of the innate immune system. They have broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses.

Full details →

Teriparatide

Teriparatide (Forteo) is recombinant human parathyroid hormone (1-34), FDA-approved for osteoporosis treatment. It's unique among osteoporosis drugs in that it stimulates new bone formation.

Full details →

Side-by-Side Comparison

Aspect	Alpha-Defensin	Teriparatide
Dose Range	100 mcg–500 mcg	20 mcg
Frequency	1x daily	1x daily
Cycle Length	2–4 weeks	52–104 weeks
Route	subcutaneous	subcutaneous
Mechanism	Insert into microbial membranes to form pores, leading to cell death. Also have immunomodulatory effects including chemotaxis of immune cells and cytokine modulation.	Intermittent PTH exposure paradoxically stimulates osteoblasts more than osteoclasts, resulting in net bone formation. Continuous exposure would cause bone loss, but pulsatile dosing builds bone.
Typical Dosage	Research compound - dosing varies by application. Typically studied in laboratory and early clinical research settings rather than for general use.	20mcg subcutaneously once daily. Maximum treatment duration of 2 years due to theoretical osteosarcoma risk from rat studies.
Administration	Various routes studied including topical, local injection, and systemic administration depending on application.	Subcutaneous injection in thigh or abdomen once daily. Delivered via multi-dose pen. Should sit or lie down after injection due to orthostatic hypotension risk.
Side Effects	Limited human use data. May cause local inflammation. Potential for immune activation effects.	Orthostatic hypotension, leg cramps, nausea, dizziness, headache, and injection site reactions. Transient hypercalcemia possible.
Best For	Recovery & Healing Immune Support	Recovery & Healing